HIGH-DOSE COMBINATION ALKYLATING AGENT CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT FOR METASTATIC BREAST-CANCER

被引：138

作者：

EDER, JP ^{[1
]}

ANTMAN, K ^{[1
]}

PETERS, W ^{[1
]}

HENNER, WD ^{[1
]}

ELIAS, A ^{[1
]}

SHEA, T ^{[1
]}

SCHRYBER, S ^{[1
]}

ANDERSEN, J ^{[1
]}

COME, S ^{[1
]}

SCHNIPPER, L ^{[1
]}

FREI, E ^{[1
]}

机构：

[1] BETH ISRAEL HOSP,DANA RES INST,DEPT MED,DIV MED ONCOL,BOSTON,MA 02215

来源：

关键词：

D O I：

10.1200/JCO.1986.4.11.1592

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1592 / 1597

页数：6

共 23 条

[1] ANTMAN K, ACCOMPLISHMENTS CANC
[2] A CONFIDENCE-INTERVAL FOR THE MEDIAN SURVIVAL-TIME
BROOKMEYER, R
CROWLEY, J
[J]. BIOMETRICS, 1982, 38 (01) : 29 - 41
[3] MANAGEMENT OF INFLAMMATORY CARCINOMA OF THE BREAST - A COMBINED MODALITY APPROACH
FASTENBERG, NA
BUZDAR, AU
MONTAGUE, ED
JESSUP, JM
MARTIN, RG
HORTOBAGYI, GN
BLUMENSCHEIN, GR
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (02): : 134 - 141
[4] FISHER B, 1983, BREAST CANCER, P93
[5] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY
FREI, E
CANELLOS, GP
[J]. AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) : 585 - 594
[6] ALKYLATING AGENT RESISTANCE - INVITRO STUDIES WITH HUMAN CELL-LINES
FREI, E
CUCCHI, CA
ROSOWSKY, A
TANTRAVAHI, R
BERNAL, S
ERVIN, TJ
RUPRECHT, RM
HASELTINE, WA
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (07) : 2158 - 2162
[7] GALE RP, 1985, INT J CELL CLONING, V3, P258
[8] MEMBRANE-TRANSPORT OF ALKYLATING-AGENTS
GOLDENBERG, GJ
BEGLEITER, A
[J]. PHARMACOLOGY & THERAPEUTICS, 1980, 8 (02) : 237 - 274
[9] GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727
[10] GREENSPAN E M, 1963, J Mt Sinai Hosp N Y, V30, P246